Skip to main content

Table 1 Involving published articles after systematic retrieval

From: The roles of iodized oil-based lymphangiography and post-lymphangiographic computed tomography for specific lymphatic intervention planning in patients with postoperative lymphatic fistula: a literature review and case series

Year

Author and reference

Patient number

Clinical presentation

Performance of LAG and post-LAG CT

Types of percutaneous intervention after LAG

Guidance modality

Agents

Technical success

Clinical success

2002

Cope C, et al. (Cope and Kaiser 2002)

42

Chylothorax

TL

TDE

Fluoroscopy

Coils, PVA, or NBCA.

89.6%

84.6%

TDD

21- or 22-gauge needle

43.8%

2005

Binkert CA, et al. (Binkert, Yucel et al. 2005)

8

Chylothorax

TL

TDE

Fluoroscopy

Coils + NBCA

100.0%

100.0%

TDD

21-gauge needle

100.0%

2008

Boffa DJ, et al. (Boffa et al. 2008)

37

Chylothorax

TL

TDE

Fluoroscopy

NBCA ± coils

57.1%

100.0%

TDD

22-gauge needle

66.7%

2010

Itkin M, et al. (Itkin et al. 2010)

109

Chylothorax/chylopericardium/cervical chylous fistula

TL

TDE

Fluoroscopy

NBCA or Onyx ± coils

67.0%

90.1%

TDD

21- or 22-gauge needle

72.2%

2014

Kortes N, et al. (Kortes et al. 2014)

18

Inguinal lymphocele/pelvic lymphocele/abdominal lymphatic leakage/chylothorax

TL and post-LAG CT

ALVS

CT

Ethanol

100.0%

77.8%

2016

Baek Y, et al. (Baek et al. 2016a)

5

Pelvic lymphocele

INL

ALVE

Fluoroscopy

NBCA

100.0%

75.0%

2016

Baek Y, et al. (Baek et al. 2016b)

21

Pelvic lymphatic leakage

INL

DLE

Fluoroscopy

NBCA

100.0%

85.0%

ALVE

NBCA

TNE

NBCA

2016

Hur S, et al. (Hur et al. 2016)

27

Chylothorax / chylous ascites/lymphoceles / skin fistula

INL

DLE

Fluoroscopy / Cone-beam CT

NBCA

89.3%

93.8%

ALVE

NBCA

TNE

NBCA

2017

Kariya S, et al. (Kariya, Nakatani et al. 2017)

5

Chylothorax

INL

TDE

Fluoroscopy

NBCA

100.0%

100.0%

2017

Yannes M, et al. (Yannes et al. 2017)

57

Chylothorax

INL

TDE

Fluoroscopy / CT / Sonography

NBCA + Coils

63.6%

90.5%

TDD

21- or 22-gauge needle

41.7%

2018

Majdalany BS, et al. (Majdalany et al. 2018)

11

Chylothorax

INL

TDE

Fluoroscopy

NBCA ± Coils

37.5%

100.0%

TDD

22-gauge needle

66.7%

2018

Nadolski GJ, et al. (Nadolski and Itkin 2018)

31

Refractory chylous ascites

TL/INL

DLE

Fluoroscopy

Coils + NBCA

100.0%

81.8%

TNE

NBCA

2018

Nadolski GJ, et al. (Nadolski and Itkin 2018)

50

Chylothorax

TL/INL

TDE

Fluoroscopy

Coils + NBCA, NBCA, Onyx, or autologous blood.

98.0%

91.8%

TDD

21or 22-gauge needle

0.0%

2018

Reisenauer JS, et al. (Reisenauer et al. 2018)

97

Chylothorax

TL

TDE

Fluoroscopy

Coils, NBCA, Onyx, or Gelfoam.

47.5%

78.9%

2018

Smolock AR, et al. (Smolock et al. 2018)

10

Inguinal lymphocele and lymphorrhea

INL

TNE

Fluoroscopy

NBCA

100.0%

80.0%

2018

Yildirim IO, et al. (Yildirim et al. 2018)

13

Pelvic lymphocele

INL

DLE

Fluoroscopy / Cone-beam CT

NBCA

100.0%

88.9%

2018

Chu HH, et al. (Chu et al. 2019)

9

Pelvic Lymphocele

INL

DLE

Fluoroscopy

NBCA

100.0%

100.0%

TNE

NBCA

2019

Kim SW, et al. (Kim et al. 2019)

33

Pelvic lymphocele

INL

TNE

Fluoroscopy / Sonography

NBCA

100.0%

83.3%

DLS

Ethanol

43.8%

  1. Abbreviation: ALVE Afferent lymphatic vessel embolization, ALVS Afferent lymphatic vessel sclerotherapy, DLE Direct leakage embolization, DLS Direct leakage sclerotherapy, INL Intranodal iodized oil-based lymphangiography, NBCA N-butyl cyanoacrylate, PVA Polyvinyl alcohol, post-LAG CT Post-lymphangiographic computed tomography, TDE Percutaneous thoracic duct embolization, TDD Percutaneous thoracic duct disruption, TL Trans-pedal iodized oil-based lymphangiography, TNE Trans-nodal embolization